Results 161 to 170 of about 14,935 (222)

Large Volume Leukapheresis in a Patient With Meniere's Disease. [PDF]

J Clin Apher
Cooling L.
europepmc   +1 more source

Health care resource utilization and costs of patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapies across different settings of care: A real-world data analysis. [PDF]

J Manag Care Spec Pharm
Patel AR, Hasegawa K, Pandya S, Shi L, Lau C, Zhao X, Near AM, Locke FL.   +7 more
europepmc   +1 more source

Ultra-low extracorporeal volume microfluidic leukapheresis is safe and effective in a rat model. [PDF]

Nat Commun
Iqbal M, McLennan AL, Mukhamedshin A, Dinh MTP, Liu Q, Junco JJ, Mohan A, Srivaths PR, Rabin KR, Fogarty TP, Gifford SC, Shevkoplyas SS, Lam FW.   +12 more
europepmc   +1 more source

Microbiological risk assessment during the procurement and processing of cells, tissues and breast milk using the MiRCA tool. [PDF]

Sci Rep
Jandová M, Rudolfová Š, Švorcová M, Měřička P.   +3 more
europepmc   +1 more source

Baseline Cognitive and Neurological Status Does Not Modify the Occurrence of ICANS in CAR T-Cell Therapy for Aggressive B-Cell Lymphoma. [PDF]

Eur J Neurol
Ursu R, Barsan C, Di Blasi R, Belin C, Cuzzubbo S, El Soudany M, Cristinelli C, Sivapragassame R, Ouedrani A, Thieblemont C, Caillat-Zucman S, Carpentier AF.   +11 more
europepmc   +1 more source

First-in-Human Study of MDG1011, a TCR-T Therapy Directed Against HLA-A*02:01-Restricted PRAME Antigen for High-Risk Myeloid and Lymphoid Neoplasms. [PDF]

Cancers (Basel)
Thomas S, Wermke M, Vučinić V, Wagner-Drouet E, Mackensen A, Zeiser R, Bug G, Schmitt M, Herr W, Prinz PU, Bürdek M, Raffegerst S, Tafuri A, Geiger C, Crame K, Goedkoop R, Pinkernell K, Schendel DJ.   +17 more
europepmc   +1 more source

Development and Evaluation of a Novel Relatively Low-Cost Method to Derive HIV-1 Integration Sites and Proviral Sequences. [PDF]

Viruses
Hardy SR, Styrchak S, De Meyer T, Lambrechts L, Struyve T, Cole B, Termote L, McLaughlin S, Mullins JI, Vandekerckhove L, Frenkel LM.   +10 more
europepmc   +1 more source

Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL. [PDF]

Cancer Discov
Su YJ, Kramer AM, Hamilton MP, Agarwal N, Srinagesh HK, Baird JH, Sahaf B, Kuo A, Ehlinger ZJ, Desai MH, Rietberg SP, Tunuguntla R, Patel S, Chinnasamy H, Gkitsas-Long N, Klysz DD, Brown AK, Bharadwaj S, Dahiya S, Smith M, Muffly L, Mackall CL, Good Z, Feldman SA, Miklos DB, Frank MJ.   +25 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hyperleukocytosis, leukostasis and leukapheresis: Practice management

Blood Reviews, 2012
Hyperleukocytosis, arbitrarily defined in acute leukemia as a white blood cell count greater than 100,000/mL, often is associated with increased morbidity and mortality in patients with leukemic processes. It can induce leukostasis, tumor lysis syndrome and disseminated intravascular coagulopathy and has significant prognostic implications with or ...
Chezi Ganzel, Jacob M Rowe
exaly   +3 more sources

Therapeutic leukapheresis

Transfusion Science, 1991
For the majority of leukemic patients, leukapheresis represents emergency treatment aimed at reducing the number of white blood cells and producing an immediate improvement in the clinical picture. We have shown that leukapheresis procedures performed for the therapy of leukocytosis in 4 patients with acute leukemia (2 myelocytic; 1 lymphocytic; 1 ...
Milan Radovic, Bela Balint, Ljubomir Milenkovic, Ljerka Tiska-Rudman, Jovan Taseski   +4 more
openaire   +2 more sources